Betrayed, But Not Defeated novel Chapter 221

Amelia sprinted away clumsily, but Daniel had already seen what she was capable of.

She was an interesting person, no doubt. But today, Daniel had far more pressing matters to handle.

Conor had sent word that the genetic serum was ready. It had officially entered the clinical trial phase!

For the Ashcroft Group, this was nothing short of a groundbreaking moment.

Inside the lab, Conor held up a vial containing a faintly glowing green liquid.

"This is the X-type genetic serum," he announced. "It's been engineered using the genetic longevity formula. However, the effects are limited. It can only be used to treat congenital heart disease."

His voice carried a hint of regret. Despite his words, the excitement on his face was unmistakable.

Although the effects were limited, the fact that it could cure congenital heart disease was more than enough to shake the world!

The Ashcroft Group needed to start making profits. Daniel had already poured a fortune into the company. If they didn't start seeing results soon, it could put serious pressure on the business.

"Good work, Mr. Fuentes!"

Daniel was more than satisfied.

Even if the X-type genetic serum effects were limited, for those who had been obsessively chasing the genetic longevity formula, this discovery would send shockwaves through them.

And that was exactly what Daniel wanted.

He wanted to speed up their actions and force their hand.

"But there's a problem," Conor said hesitantly. "We're going to run into difficulties getting the serum approved for clinical trials.

"We need a specialized hospital to assist us. Unfortunately, we don't have the necessary credentials right now."

He paused before adding, "The company's previous licensing expired due to time constraints. If we want the X-type genetic serum to hit the market, we'll need to reapply for approval."

"I'll take care of it."

Daniel waved a hand dismissively.

Conor went on to introduce several other genetic serums that were still in development. These were projects that had been shelved for various reasons in the past.

The skyrocketing valuation of the Ashcroft Group was heavily tied to its genetic research.

And under Conor's constant supervision, the progress had been remarkable.

But now, there was no time to waste. They needed to push forward.

Daniel thought for a moment.